BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28863456)

  • 1. Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
    Ryall S; Arnoldo A; Krishnatry R; Mistry M; Khor K; Sheth J; Ling C; Leung S; Zapotocky M; Guerreiro Stucklin A; Lassaletta A; Shago M; Tabori U; Hawkins CE
    J Neuropathol Exp Neurol; 2017 Jul; 76(7):562-570. PubMed ID: 28863456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel GIT2-BRAF fusion in pilocytic astrocytoma.
    Helgager J; Lidov HG; Mahadevan NR; Kieran MW; Ligon KL; Alexandrescu S
    Diagn Pathol; 2017 Nov; 12(1):82. PubMed ID: 29141672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene.
    Sievert AJ; Jackson EM; Gai X; Hakonarson H; Judkins AR; Resnick AC; Sutton LN; Storm PB; Shaikh TH; Biegel JA
    Brain Pathol; 2009 Jul; 19(3):449-58. PubMed ID: 19016743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.
    Dougherty MJ; Santi M; Brose MS; Ma C; Resnick AC; Sievert AJ; Storm PB; Biegel JA
    Neuro Oncol; 2010 Jul; 12(7):621-30. PubMed ID: 20156809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
    Hardin EC; Schmid S; Sommerkamp A; Bodden C; Heipertz AE; Sievers P; Wittmann A; Milde T; Pfister SM; von Deimling A; Horn S; Herz NA; Simon M; Perera AA; Azizi A; Cruz O; Curry S; Van Damme A; Garami M; Hargrave D; Kattamis A; Kotnik BF; Lähteenmäki P; Scheinemann K; Schouten-van Meeteren AYN; Sehested A; Viscardi E; Wormdal OM; Zapotocky M; Ziegler DS; Koch A; Hernáiz Driever P; Witt O; Capper D; Sahm F; Jones DTW; van Tilburg CM
    Neuro Oncol; 2023 Nov; 25(11):2087-2097. PubMed ID: 37075810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional KIAA1549:BRAF mice reveal brain region- and cell type-specific effects.
    Kaul A; Chen YH; Emnett RJ; Gianino SM; Gutmann DH
    Genesis; 2013 Oct; 51(10):708-16. PubMed ID: 23893969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
    Rodriguez FJ; Vizcaino MA; Lin MT
    J Mol Diagn; 2016 Sep; 18(5):620-634. PubMed ID: 27444975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ARIH1::BRAF fusion in a glioma.
    Xu E; Stone SL; Zhong Y; Golenberg N; Qiu L; Abdullaev Z; Aldape K; Bagley L; Halpern CH; Amankulor N; Nasrallah MP
    J Neuropathol Exp Neurol; 2023 Oct; 82(11):966-969. PubMed ID: 37742132
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.
    Nikiforova MN; Wald AI; Melan MA; Roy S; Zhong S; Hamilton RL; Lieberman FS; Drappatz J; Amankulor NM; Pollack IF; Nikiforov YE; Horbinski C
    Neuro Oncol; 2016 Mar; 18(3):379-87. PubMed ID: 26681766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning.
    Tak D; Ye Z; Zapaischykova A; Zha Y; Boyd A; Vajapeyam S; Chopra R; Hayat H; Prabhu SP; Liu KX; Elhalawani H; Nabavizadeh A; Familiar A; Resnick AC; Mueller S; Aerts HJWL; Bandopadhayay P; Ligon KL; Haas-Kogan DA; Poussaint TY; Kann BH
    Radiol Artif Intell; 2024 May; 6(3):e230333. PubMed ID: 38446044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult pilocytic astrocytomas: clinical features and molecular analysis.
    Theeler BJ; Ellezam B; Sadighi ZS; Mehta V; Tran MD; Adesina AM; Bruner JM; Puduvalli VK
    Neuro Oncol; 2014 Jun; 16(6):841-7. PubMed ID: 24470550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
    Raabe E; Kieran MW; Cohen KJ
    Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-pronged analysis of pediatric low-grade glioma reveals a unique tumor microenvironment associated with BRAF alterations.
    Zahedi S; Riemondy K; Griesinger AM; Donson AM; Fu R; Crespo M; DeSisto J; Groat MM; Bratbak E; Green A; Hankinson TC; Handler M; Vibhakar R; Willard N; Foreman NK; Levy JM
    bioRxiv; 2024 Apr; ():. PubMed ID: 38645202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
    Haas-Kogan DA; Aboian MS; Minturn JE; Leary SES; Abdelbaki MS; Goldman S; Elster JD; Kraya A; Lueder MR; Ramakrishnan D; von Reppert M; Liu KX; Rokita JL; Resnick AC; Solomon DA; Phillips JJ; Prados M; Molinaro AM; Waszak SM; Mueller S
    J Clin Oncol; 2024 Feb; 42(4):441-451. PubMed ID: 37978951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
    Selt F; El Damaty A; Schuhmann MU; Sigaud R; Ecker J; Sievers P; Kocher D; Herold-Mende C; Oehme I; von Deimling A; Pfister SM; Sahm F; Jones DTW; Witt O; Milde T
    J Neurooncol; 2023 Dec; 165(3):467-478. PubMed ID: 37999877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
    Kilburn LB; Khuong-Quang DA; Hansford JR; Landi D; van der Lugt J; Leary SES; Driever PH; Bailey S; Perreault S; McCowage G; Waanders AJ; Ziegler DS; Witt O; Baxter PA; Kang HJ; Hassall TE; Han JW; Hargrave D; Franson AT; Yalon Oren M; Toledano H; Larouche V; Kline C; Abdelbaki MS; Jabado N; Gottardo NG; Gerber NU; Whipple NS; Segal D; Chi SN; Oren L; Tan EEK; Mueller S; Cornelio I; McLeod L; Zhao X; Walter A; Da Costa D; Manley P; Blackman SC; Packer RJ; Nysom K
    Nat Med; 2024 Jan; 30(1):207-217. PubMed ID: 37978284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
    Fangusaro J; Jones DT; Packer RJ; Gutmann DH; Milde T; Witt O; Mueller S; Fisher MJ; Hansford JR; Tabori U; Hargrave D; Bandopadhayay P
    Neuro Oncol; 2024 Jan; 26(1):25-37. PubMed ID: 37944912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of KIAA1549::BRAF fusions and clinicopathological insights of pilocytic astrocytomas.
    Dandapath I; Das S; Charan BD; Garg A; Suri A; Kedia S; Sharma MC; Sarkar C; Khonglah Y; Ahmed S; Suri V
    Ann Diagn Pathol; 2024 Apr; 72():152318. PubMed ID: 38733671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tovorafenib effective against low-grade gliomas harbouring BRAF fusions.
    Sidaway P
    Nat Rev Clin Oncol; 2024 Feb; 21(2):83. PubMed ID: 38082106
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment.
    Tsai JW; Choi JJ; Ouaalam H; Murillo EA; Yeo KK; Vogelzang J; Sousa C; Woods JK; Ligon KL; Warfield SK; Bandopadhayay P; Cooney TM
    Neurooncol Adv; 2023; 5(1):vdac182. PubMed ID: 36926246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.